Sponsor:
Pulmonary Fibrosis Foundation
Code:
NCT05382572
Conditions
Pulmonary Fibrosis
Interstitial Lung Disease
Lung Fibrosis
Idiopathic Pulmonary Fibrosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Pulmonary Fibrosis
Interstitial Lung Disease
Lung Fibrosis
Idiopathic Pulmonary Fibrosis
Study ID
NCT05382572
Start date
Jul 11, 2022
Status verified date
Apr, 2025
Completion date
Jul 1, 2027
Anticipated
Primary completion date
Jul 1, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
10000 participants
Anticipated
Arms
Patients
Family Members
Caregivers
Primary outcome measure
Central contacts
Locations
Pulmonary Fibrosis Foundation
Recruiting
Chicago, Illinois, United States, 60611
Contacts
Principal Investigator:
Kevin Flaherty, MD
Sponsor
Pulmonary Fibrosis Foundation
Last update posted
Apr 11, 2025
Last verified
Apr, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Pulmonary Fibrosis Foundation on 2025-04-11.